choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Amaryl

Amaryl Newsletter
  • Emcure Pharmaceuticals Witnesses a Growth Spurt 29 Jan 2026 23:01 GMT

    … . Its pharmaceutical industry is currently diving into custom treatments based on … . Strategy: Just what the doctor ordered Emcure has leveled up … fuel their dominance in the medical field. Emcure is the … locked down the diabetes (Amaryl and Cetapin) and heart …

  • How 300% cost spike, drug rationing turn diabetes to death threat 16 Jan 2026 05:45 GMT

    … either ration drugs, abandon treatment or turn to unproven herbal remedies, which … now costs N5,000. Amaryl 4 mg, which was … medications are imported. So, reducing the tax waiver on pharmaceuticals … about four stages of clinical trials.” Like DAN, Corporate …

  • One of the Most Common Diabetes Treatments May Be Making the Disease Worse, Study Warns 04 Jan 2026 08:35 GMT

    … frequently prescribed medications for the disease. Common examples include glimepiride (Amaryl), glipizide … face of sulfonylureas Sulfonylureas are drugs capable of interacting directly … efficacy of sulfonylureas in the treatment of diabetes and their …

  • Emcure launches ₹2,200-a-week weight-loss drug in Novo Nordisk partnership 22 Dec 2025 12:44 GMT

    MUMBAI: Emcure Pharmaceuticals launched weight loss drug Poviztra on … headquartered firm expects the drug to be a … cheaper generics. Several Indian drugmakers, including Sun Pharma, … -diabetic (OAD) products, like Amaryl (Glimepiride) and Cetapin (Metformin …

  • 10 Medications That Don’t Mix Well With Coffee 18 Oct 2025 07:28 GMT

    … the effects of the antidepressant and exacerbate medication symptoms (such as … opposite effect of antidiabetic drugs like glimepiride (Amaryl), glyburide (DiaBeta, Glynase … ’re taking blood pressure medication, your doctor may recommend avoiding caffeine …

  • NAFDAC Clarifies Status Of 101 Withdrawn Drugs 14 Oct 2025 13:36 GMT

    … categories, including antimalarials, antimicrobials, diabetes medicines, eye drops, and injectables. Among … for commercial reasons. Other affected drugs included Flagyl Suspension and Tablets … the market, while Amaryl M Tablets and Amaryl M SR were voluntarily …

  • NAFDAC Clarifies Withdrawal of 101 Medicines Amid Nationwide Crackdown on Unsafe Drugs 14 Oct 2025 11:12 GMT

    … Limited’s Artemether/Lumefantrine pills and Sanofi Aventis’ ASAQ (Artesunate … usable. Withdrawals included medications like Januvia, Janumet, and Amaryl M tablets in … vaccines. While fake cosmetics and drugs worth N1.5 billion were …

  • NAFDAC clarifies withdrawal of 101 drugs in Nigeria 14 Oct 2025 10:02 GMT

    … affected products  Among the affected medicines, several well-known brands were … drug category, Januvia (50mg & 100mg), Janumet (50mg/850mg), and Amaryl … crackdown on counterfeit and expired medical products, conducting multiple high-profile …

  • NAFDAC destroys fake and expired drugs worth N15 billion in Ibadan  02 Oct 2025 18:19 GMT

    … citizens to report suspicious drug activities to protect lives and … includes commonly used medicines such as Abacavir tablets, Amaryl tablets, Amlodipine, … several cardiovascular and diabetes treatments from global pharmaceutical companies like Sanofi, …

  • Emcure Pharmaceuticals Ltd and Sanofi India Ltd announce Exclusive Distribution Partnership to broaden reach of Sanofi's Oral Anti-diabetic Drugs 16 Jul 2025 22:40 GMT

    … & industry-leading OADs Amaryl® and Cetapin®. This partnership … and Managing Director, Emcure Pharmaceuticals Ltd. "At Emcure … trusted oral anti-diabetic medicines will be available to … quot; Shares of Emcure Pharmaceuticals Limited was last trading …

Satisfied with the content?

Continue to create your account.